Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
198.70    1.50 (0.76%)
Bid:
197.70
Ask:
198.00
Spread: 0.30 (0.152%)
Market Cap: £1.71b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Directorate Change

14 Mar 2018 13:53

RNS Number : 7373H
Premier Foods plc
14 March 2018
 

 

 

Premier Foods plc ("Premier Foods" or the "Company")

14 March 2018

 

Board Retirement

 

Premier Foods announces that Tsunao Kijima, non-executive director, has advised the Company today that he intends to stand down as a director of Premier Foods on 23 March 2018, following his decision to retire from Nissin Foods Holdings Company Ltd ("Nissin"). Mr Kijima has served on the Board since July 2016 pursuant to the terms of the Relationship Agreement between the Company and Nissin.

 

Board Appointment

 

Following Mr Kijima's retirement, Shinji Honda will be appointed as a non-executive director and as Nissin's representative director pursuant to the Relationship Agreement, with effect from 23 March 2018.

 

Mr Honda is Chief Strategy Officer of Nissin, with responsibility for overseas operations, including Europe. Prior to joining Nissin in January 2018, Mr Honda spent his entire professional career at Takeda Pharmaceutical Company Limited ("Takeda"), a leading Japanese pharmaceutical company. He was named Member of the Board of Takeda in June 2013 and Corporate Strategy Officer in October 2014, having previously spent a significant amount of time overseeing Takeda's international operations where his responsibilities included President and CEO of Takeda North America.

 

Commenting on the changes Keith Hamill, Chairman of Premier Foods, said "I would like to take this opportunity to thank Mr Kijima for his significant contribution to both the Board and the partnership between Premier and Nissin, which has helped to ensure the successful launch of a number of exciting new products to market. We welcome Mr Honda to the Board and look forward to working with him in the future".

 

Mr Honda served as Member of the Board of Takeda Pharmaceutical Company Limited (listed on the first section of the Tokyo Stock Exchange) from June 2013 until June 2017. No further information is required to be disclosed pursuant to LR 9.6.13 R.

For further information please contact:

Andrew McDonald, General Counsel & Company Secretary +44 (0) 1727 815 850

Hannah Collyer, Corporate Affairs Director +44 (0) 1727 815 850

Richard Godden, Director of Investor Relations +44 (0) 1727 815 850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAXZLFFVXFEBBF
Date   Source Headline
15th Feb 20117:00 amRNSFinal Results
8th Feb 20117:00 amRNSDisposal
24th Jan 20118:52 amRNSDisposal
12th Jan 20117:00 amRNSNotification of Preliminary Results 2010
7th Dec 20103:30 pmRNSDirectorate Change
3rd Dec 20107:00 amRNSStatement re. Press Comment
17th Nov 20107:00 amRNSStatement re Canning
1st Nov 20102:03 pmRNSTotal Voting Rights
28th Oct 20107:00 amRNSInterim Management Statement
19th Oct 20107:00 amRNSSWAP Restructure Completed
15th Oct 201011:46 amRNSDirector/PDMR Shareholding
4th Oct 20107:00 amRNSStatement re press comment
1st Oct 20109:05 amRNSBlocklisting Interim Review
1st Oct 20109:00 amRNSTotal Voting Rights
29th Sep 201012:00 pmRNSNotice of Interim Management Statement
1st Sep 201010:09 amRNSTotal Voting Rights
4th Aug 20107:01 amRNSHalf Yearly Report
2nd Aug 20109:08 amRNSTotal Voting Rights
1st Jul 20101:17 pmRNSTotal Voting Rights
30th Jun 20107:00 amRNSDirectorate Change
1st Jun 20109:20 amRNSTotal Voting Rights
26th May 20101:04 pmRNSDirector/PDMR Shareholding
20th May 20104:51 pmRNSResult of AGM
7th May 20101:38 pmRNSAnnual Information Update
30th Apr 20102:00 pmRNSTotal Voting Rights
27th Apr 20107:00 amRNSInterim Management Statement
14th Apr 20109:00 amRNSNotification of Interim Management Statement
1st Apr 20108:55 amRNSDirector/PDMR Shareholding
31st Mar 20104:51 pmRNSDirector Declaration
31st Mar 20101:46 pmRNSTotal Voting Rights
31st Mar 20101:08 pmRNSBlocklisting Interim Review
31st Mar 201010:00 amRNSDirector/PDMR Shareholding
29th Mar 20101:49 pmRNSAnnual Financial Report
24th Mar 20104:04 pmRNSDirector/PDMR Shareholding
24th Mar 201010:04 amRNSDirector/PDMR Shareholding
2nd Mar 20102:56 pmRNSTotal Voting Rights
17th Feb 201011:03 amRNSDirector/PDMR Shareholding
16th Feb 20107:00 amRNSFinal Results
1st Feb 201011:40 amRNSHolding(s) in Company
1st Feb 20109:21 amRNSTotal Voting Rights
1st Feb 20107:00 amRNSDirectorate Change
14th Jan 20107:00 amRNSTrading Statement
6th Jan 201011:28 amRNSTotal Voting Rights
24th Dec 200911:57 amRNSHolding(s) in Company
15th Dec 200911:00 amRNSNotice of Results
1st Dec 20099:00 amRNSTotal Voting Rights
16th Nov 200911:24 amRNSDirector/PDMR Shareholding
15th Oct 20097:00 amRNSInterim Management Statement
12th Oct 200910:00 amRNSDirectorate Change
9th Oct 20094:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.